Goulouti Eleni, Lam Anna, Nozica Nikolas, Elchinova Elena, Dernektsi Chrisoula, Neugebauer Felix, Branca Mattia, Servatius Helge, Noti Fabian, Haeberlin Andreas, Thalmann Gregor, Kozhuharov Nikola Asenov, Madaffari Antonio, Tanner Hildegard, Reichlin Tobias, Roten Laurent
Department of Cardiology Inselspital, Bern University Hospital, University of Bern Bern Switzerland.
Clinical Trials Unit University of Bern Switzerland.
J Am Heart Assoc. 2024 Feb 20;13(4):e032223. doi: 10.1161/JAHA.123.032223. Epub 2024 Feb 13.
Screening for atrial fibrillation (AF) may reveal incidental arrhythmias of relevance. The aim of this study was to describe incidental arrhythmias detected during screening for AF in the STAR-FIB (Predicting SilenT AtRial FIBrillation in Patients at High Thrombembolic Risk) cohort study.
In the STAR-FIB cohort study, we screened hospitalized patients for AF with 3 repeat 7-day Holter ECGs. We analyzed all Holter ECGs for the presence of the following incidental arrhythmias: (1) sinus node dysfunction, defined as sinus pause of ≥3 seconds' duration; (2) second-degree (including Wenckebach) or higher-degree atrioventricular block (AVB); (3) sustained supraventricular tachycardia of ≥30 seconds' duration; and (4) sustained ventricular tachycardia of ≥30 seconds' duration. We furthermore report treatment decisions because of incidental arrhythmias. A total of 2077 Holter ECGs were performed in 794 patients (mean age, 74.7 years; 49% women), resulting in a mean cumulative duration of analyzable ECG signal of 414±136 hours/patient. We found incidental arrhythmias in 94 patients (11.8%). Among these were sinus node dysfunction in 14 patients (1.8%), AVB in 41 (5.2%), supraventricular tachycardia in 42 (5.3%), and ventricular tachycardia in 2 (0.3%). Second-degree AVB was found in 23 patients (2.9%), 2:1 AVB in 10 (1.3%), and complete AVB in 8 (1%). Subsequently, 8 patients underwent pacemaker implantation, 1 for sinus node dysfunction (post-AF conversion pause of 9 seconds) and 7 for advanced AVB. One patient had an implantable cardioverter-defibrillator implanted for syncopal ventricular tachycardia.
Incidental arrhythmias were frequently detected during screening for AF in the STAR-FIB study and resulted in device therapy in 1.1% of our cohort patients.
心房颤动(AF)筛查可能会发现具有相关性的偶发性心律失常。本研究的目的是描述在STAR-FIB(预测高血栓栓塞风险患者的隐匿性心房颤动)队列研究中AF筛查期间检测到的偶发性心律失常。
在STAR-FIB队列研究中,我们用3次重复的7天动态心电图对住院患者进行AF筛查。我们分析了所有动态心电图,以确定是否存在以下偶发性心律失常:(1)窦房结功能障碍,定义为窦性停搏持续时间≥3秒;(2)二度(包括文氏现象)或更高程度的房室传导阻滞(AVB);(3)持续时间≥30秒的持续性室上性心动过速;(4)持续时间≥30秒的持续性室性心动过速。我们还报告了因偶发性心律失常而做出的治疗决策。794例患者共进行了2077次动态心电图检查(平均年龄74.7岁;49%为女性),每位患者可分析心电图信号的平均累积持续时间为414±136小时。我们在94例患者(11.8%)中发现了偶发性心律失常。其中,14例(1.8%)为窦房结功能障碍,41例(5.2%)为AVB,42例(5.3%)为室上性心动过速,2例(0.3%)为室性心动过速。23例患者(2.9%)发现二度AVB,10例(1.3%)发现2:1 AVB,8例(1%)发现完全性AVB。随后,8例患者接受了起搏器植入,1例因窦房结功能障碍(房颤转复后停搏9秒),7例因高度AVB。1例患者因晕厥性室性心动过速植入了植入式心脏复律除颤器。
在STAR-FIB研究中AF筛查期间经常检测到偶发性心律失常,导致1.1%的队列患者接受了器械治疗。